The social cost of drugs: an estimation in France in 2019
In a glimpse, OFDT, 2 p.
July 2023
This report presents a new estimate of the social cost of drugs in France in 2019, following a previous calculation in 2010. The results are not directly comparable, as several calculation parameters have been modified to take account of improvements in the statistical data available.
The social cost of drugs in France measures the monetary cost of the consequences of legal (alcohol and tobacco) and illegal drug use and trafficking during an average year of the decade. It is made up of the external cost (value of human lives lost, loss of production) and the cost to public finances (prevention, repression and care, savings on pensions not paid out, and revenue from taxes levied on alcohol and tobacco). The calculation parameters follow the guidelines of the Quinet report.
Download In a glimpse, the social cost of drugs: an estimation in France in 2019 (1,37 Mo, 2p.)
Drugs in Europe
2023 EMCDDA European Drug Report
The European Drug Report 2023: Trends and Developments presents the EMCDDA’s latest analysis of the drug situation in Europe. Focusing on illicit drug use, related harms and drug supply, the report contains a comprehensive set of national data across these themes and key harm-reduction interventions. This report is based on information provided to the EMCDDA by the EU Member States, the candidate country Türkiye, and Norway, in an annual reporting process.
The annual Statistical Bulletin contains the most recent available data on the drug situation in Europe provided by the Member States. These datasets underpin the analysis presented in the European Drug Report. All data may be viewed interactively on screen and downloaded in Excel format.
The European Union and the drug phenomenon
The European Union & the drug phenomenon : Frequently asked questions, joint publication between the EMCDDA and the European Commission, october 2010, 12 p.
